Free Trial
→ The Tiny Stock Set to Soar with Musk's AI Ambitions (From Behind the Markets) (Ad)tc pixel

Cybin (OTCMKTS:CLXPF) Stock Price Up 2.2% - Time to Buy?

Written by MarketBeat
October 1, 2025
Cybin logo with Medical background

Key Points

  • Cybin Inc. shares increased by 2.2% during mid-day trading, reaching a last traded price of $5.99.
  • The company has a market capitalization of $890.10 million and operates in developing psychedelic therapeutics for psychiatric and neurological conditions.
  • Despite the recent increase in stock price, the 50-day and 200-day moving averages are $6.90 and $7.17, respectively, indicating the stock is still below those levels.
  • Five stocks to consider instead of Cybin.

Shares of Cybin Inc. (OTCMKTS:CLXPF - Get Free Report) were up 2.2% during mid-day trading on Tuesday . The company traded as high as $6.00 and last traded at $5.99. Approximately 594,425 shares were traded during trading, an increase of 8% from the average daily volume of 551,962 shares. The stock had previously closed at $5.86.

Cybin Trading Up 2.2%

The stock has a 50 day moving average of $6.90 and a 200-day moving average of $7.17. The stock has a market capitalization of $890.10 million and a P/E ratio of -24.96.

Cybin Company Profile

(Get Free Report)

Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cybin Right Now?

Before you consider Cybin, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cybin wasn't on the list.

While Cybin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.